The US District Court in Delaware has adopted Enzo's interpretation of patent language and rejected the defendants' argument to invalidate a key patent.
Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.
Hologic said in its Form 10-Q that Enzo sued the firm in March alleging infringement of a patent related to labeled nucleotides for use as diagnostic tools.
The appeals court reversed in part an earlier decision by aUSdistrict court that resulted in a $61 million award to Enzo, and remanded the case back to the district court.